Noble Financial Downgrades Pharmasset (VRUS) to Sell
Tweet Send to a FriendGet Alerts VRUS Hot Sheet
Price: $136.97 --0%
Rating Summary:
5 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
5 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade VRUS Now!
Noble Financial downgraded Pharmasset (NASDAQ: VRUS) from Buy to Sell, price target raised from $95 to $135.
For an analyst ratings summary and ratings history on Pharmasset click here. For more ratings news on Pharmasset click here.
Shares of Pharmasset closed at $134.14 yesterday, with a 52 week range of $41.26-$137.81.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Pharmasset click here. For more ratings news on Pharmasset click here.
Shares of Pharmasset closed at $134.14 yesterday, with a 52 week range of $41.26-$137.81.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Goldman Sachs Downgrades Aixtron (AIXG) to Neutral
- Goldman Sachs Downgrades China Mobile (CHL) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Noble Financial
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
